Wall Street analysts questioned whether the lower-than-expected rates are final and what the prospects are for renegotiation. Shares of market leader iRhythm fell over 32% on Friday.
The nominee has made headlines since leaving the House of Representatives, in part by leading blue state efforts to defend the ACA. Less high-profile, perhaps, were his efforts to block major hospital mergers in California.
Wichmann's retirement ends his relatively short tenure at the diversified healthcare giant, and results in a leadership shakeup with Witty taking the reins immediately.
Having multiple contracts with large hospital employers up for negotiation around the same time could work to the union's advantage, one labor expert said.
In the first few months of the pandemic, more than 30% of all visits were provided via virtual care, according to a report published this week in Health Affairs.
Insulet, Dexcom and Medtronic have product launches set for this year, with all looking to capitalize on the recent skyrocketing of virtual care due to the coronavirus pandemic.
With restrictions in place, Covid-19 drove telehealth to become a necessity almost overnight. Learn how providers are ensuring patient access in this Trendline.
Healthcare Dive provides in-depth journalism and insight into the most impactful news and trends shaping healthcare. The newsletters and website cover topics such as health IT, policy & regulation, insurance, digital health, payer-provider partnerships, value-based care and more. Healthcare Dive is a leading publication operated by Industry Dive. Our business journalists spark ideas and shape agendas for 10+ million decision makers in competitive industries.
This email is optimized for display on mobile phones. Healthcare Dive: Daily Dive is a product of Industry Dive, Inc. 1255 23rd Street NW, Suite 550, Washington, DC 20037. We value your privacy. We won't share your email address with anyone else without your permission. This message was sent to edwardlorilla1986.acciyo123@blogger.com. You can unsubscribe or switch to a weekly newsletter subscription anytime. See our full privacy policy.
No comments:
Post a Comment